Skip to main content
. Author manuscript; available in PMC: 2009 Oct 25.
Published in final edited form as: Biometals. 2009 Feb 17;22(4):633–648. doi: 10.1007/s10534-009-9218-3

Table 5.

Growth inhibition activity of desferridanoxamine-Lorabid® (Dan-Lor), desferridanoxamine-ciprofloxacin (Dan-Cip), and desferridanoxamine-triclosan (Dan-Tri) conjugates relative to standards desferridanoxamine (Dan), Lorabid® (Lor), ciprofloxacin (Cip), and triclosan (Tri). 50μL of each compound solution was filled in 9 mm wells in agar media (Standard I Nutrient Agar, Serva). Inhibition zones read after incubation at 37°C for 24 h (Long, T. E., manuscript in preparation).

Test Organism/Compound Zone of Growth Inhibition (mm)
Dan
2.0 mM
Dan-Lor
2.0 mM
Lor
2.0 mM
Dan-Cip
0.2 mM
Cip
0.2 mM
Dan-Tri
0.2 mM
Tri
0.2 mM
B. subtilis ATCC 6633 0 14c/19P 34b 26 36 21 18
S. aureus SG511 0 18/26.5P 28/34.5p 25 52 41 29
S. aureus 134/94 (MRSA) 0 0 0 0 13 25 26
M. luteus ATCC 10240 0 11/16p 38/42p 0 19 16 20
M. vaccae IMET 10670 23 20.5 0b 20 44 28 32
E. faecalis 1528 (VRE) 0 0 0b 16 24.5 15 16
E. cloacae P99 12a nt 0 18 29 22.5 29
E. coli AB2847 17p 17p 25 20 33.5 25 31
E. coli BR158 19.5p 19p 27 15 34 25 31
E. coli H1876 20p 18p 28.5 18 27 27 32
E. coli HK 9/7 19.5p 19.5p 30 20.5 28 29 33.5
E. coli IV-3-2 20h 19h 25.5 0 27 28 33
E. coli DC 0 24h 19.5h 26 0 25.5 24.5 28.5
E. coli DC 2 20.5P 14/19P 31 16 31.5 44 50
P. aeruginosa K199 0 0 0 0 25 0 0
P. aeruginosa K648 0 0 0 0 33 0 0
P. aeruginosa IV-3-13 0 0 0 0 35 0 15P
P. aeruginosa 799/WT 0 0 0 17P 39 0 0
P. aeruginosa 799/61 0 15/23p/40h 23/27p 18 43 0 0

c = single colonies in the inhibition zone

p = partially clear inhibition zone/colonies in the inhibition zone

P = unclear inhibition zone/many colonies in the inhibition zone

h = faint indication of inhibition zone

nt = not tested

a

Concentration = 0.5 mM

b

Concentration = 0.2 mM